Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

1
Player Avatar shotgun06 (< 20) Submitted: 7/23/2014 4:20:17 PM : Outperform Start Price: $91.56 GILD Score: +5.63

Look at the products that they have and have in trials. The need for these products are very large!

Featured Broker Partners


Advertisement